世界の医療用メンブレン市場2020年-2027年:材料別(アクリル、ポリプロピレン(PP)、ポリフッ化ビニリデン(PVDF)、ポリスルホン(PSU)&ポリエーテルスルホン(PESU)、ポリテトラフルオロエチレン(PTFE)、その他)、技術別、用途別

◆英語タイトル:Medical Membrane Market by Material (Acrylics, Polypropylene (PP) Polyvinylidene fluoride (PVDF), Polysulfone (PSU) & Polyether Sulfone (PESU), Polytetrafluoroethylene (PTFE), and Others), Technology (Microfiltration, Ultrafiltration, Nanofiltration, Dialysis, Gas Filtration, and Others) and Application (Pharmaceutical Filtration, IV Infusion & Sterile Filtration, Bio-artificial Processes, Drug Delivery, Hemodialysis, and Others): Global Opportunity Analysis and Industry Forecast 2020–2027
◆商品コード:ALD21FB016
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年12月
◆ページ数:249
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥657,666見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥735,300見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥1,025,430見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Allied Market Research社の本調査レポートでは、世界の医療用メンブレン市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、材質別(アクリル、ポリプロピレン(PP)、ポリフッ化ビニリデン(PVDF)、ポリスルホン(PSU)&ポリエーテルスルホン(PESU)、ポリテトラフルオロエチレン(PTFE))分析、技術別(マイクロろ過、限外ろ過、ナノろ過、透析、ガスろ過 )分析、用途別(医薬品ろ過、IV注入&滅菌ろ過、バイオ人工プロセス、ドラッグデリバリー、血液透析)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の医療用メンブレン市場規模:材質別(アクリル、ポリプロピレン(PP)、ポリフッ化ビニリデン(PVDF)、ポリスルホン(PSU)&ポリエーテルスルホン(PESU)、ポリテトラフルオロエチレン(PTFE))
・世界の医療用メンブレン市場規模:技術別(マイクロろ過、限外ろ過、ナノろ過、透析、ガスろ過 )
・世界の医療用メンブレン市場規模:用途別(医薬品ろ過、IV注入&滅菌ろ過、バイオ人工プロセス、ドラッグデリバリー、血液透析)
・世界の医療用メンブレン市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

The global medical membrane market was valued at $2.73 billion in 2019, and is projected to reach $5.81 billion by 2027, growing at a CAGR of 9.8% from 2020 to 2027.

A medical membrane is a synthetically produced membrane that is used in the healthcare industry or in the laboratory for separation purposes. Since the mid-twentieth century, medical membranes have been successfully used in large- and small-scale manufacturing processes. The major factor that drives the growth of the global medical membrane market is increase in use of medical membrane in hemodialysis and pharmaceutical filtration. In different medical applications, such as venting & gas filtration, pre-filtration, sterile filtration, infusion therapy, and sample preparation, these membranes are commonly used. In aqueous solution, the medical membrane offers superior flow and fast filtration rate to flush out bacteria, fine particles, and fungi. Thus, owing to increase in applications across several industries such as healthcare, biotechnology, and pharmaceuticals , the medical membrane market has witnessed unparalleled growth over the last few decades.

In emerging economies, surge in demand for medical membranes is anticipated to fuel market growth. Factors further driving market growth are rise in demand for artificial organs and the need for high-purity selective separation. In addition, medical membranes are widely used to manufacture and preserve high-quality goods in the healthcare industry. They deliver benefits such as elevated selectivity and permeability. One of the most important applications of the semi-permeable membrane in the artificial treatment of blood is hemodialysis. However, high capital expenditure for membrane and surface fouling production are expected to impede the growth of the global medical membrane industry.

The global medical membrane market is segmented into material, technology, applications, and region. By material, the market is classified into acrylics, polypropylene (PP), polyvinylidene fluoride (PVDF), polysulfone (PSU) & polyether sulfone (PESU), polytetrafluoroethylene (PTFE), and others. Depending on technology, it is segregated into microfiltration, ultrafiltration, nanofiltration, dialysis, gas filtration, and others. On the basis of application, it is fragmented into pharmaceutical filtration, IV infusion & sterile filtration, bio-artificial processes, drug delivery, hemodialysis, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the key players operating in the global medical membrane market are Amniox Medical, Asahi Kasei, Danaher Corporation, Hangzhou Cobetter Filtration Equipment, Koch Membrane Systems, Merck Group, Mann+Hummel, Sartorius AG, W. L. Gore & Associates, and 3M Company.

KEY BENEFITS FOR STAKEHOLDERS
 The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global medical membrane market from 2019 to 2027 to determine the prevailing opportunities.
 A comprehensive analysis of the factors that drive and restrict the growth of the market is provided.
 Estimations and forecast are based on factors impacting the market growth, in terms of both value and volume.
 Profiles of leading players operating in the market are provided to understand the global competitive scenario.
 The report provides extensive qualitative insights on the significant segments and regions exhibiting favorable market growth
IMPACT OF COVID-19 ON THE GLOBAL MEDICAL MEMBRANE MARKET
• The world is battling the contagious COVID-19 pandemic, which has spread across the globe.
• Some of the major economies suffering the COVID-19 crises include Germany, France, Italy, Spain, the UK, and Norway.
• Medical membrane is primarily used in pharmaceutical filtration, IV infusion & sterile filtration, bio-artificial processes, drug delivery, and hemodialysis; and as an impact of national lockdown, these sectors were experiencing a slight decline in growth rates.
• In many countries, the economy has dropped due to the halt of several industries, especially transport and supply chain. Demand for the product has been hindered as there is no development due to the lockdown.
• The demand supply gap, disruptions in raw material procurement, and price volatility are expected to hamper the growth of the chemical industry during the COVID-19 pandemic.

KEY MARKET SEGMENTS
• By Material
 Acrylics
 Polypropylene (PP)
 Polyvinylidene Fluoride (PVDF)
 Polysulfone (PSU) & Polyether Sulfone (PESU)
 Polytetrafluoroethylene (PTFE)
 Others

• By Technology
 Microfiltration
 Ultrafiltration
 Nanofiltration
 Dialysis
 Gas Filtration
 Others

• By Application
 Pharmaceutical Filtration
 IV Infusion & Sterile Filtration
 Bio-Artificial Processes
 Drug Delivery
 Hemodialysis
 Others

• By Region
o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 France
 Italy
 Spain
 UK
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 South Korea
 Australia
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Saudi Arabia
 South Africa
 Rest of LAMEA

KEY MARKET PLAYERS
• Amniox Medical
• Asahi Kasei
• Danaher Corporation
• Hangzhou Cobetter Filtration Equipment
• Koch Membrane Systems
• Merck Group
• Mann+Hummel
• Sartorius AG
• W. L. Gore & Associates
• 3M Company

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research

1.5.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Growing popularity of medical membrane to propel market growth
3.4.1.2.Rise in demand for artificial organs

3.4.2.Restraint

3.4.2.1.Long in-process validation process

3.4.3.Opportunity

3.4.3.1.Growing demand for medical membranes in emerging economies

3.5.Patent analysis

3.5.1.Patent analysis by country (2013-2020)

3.6.Impact of government rules and regulations
3.7.Impact of corona (COVID 19) outbreak on the global medical membrane market

CHAPTER 4:MEDICAL MEMBRANE MARKET, BY MATERIAL

4.1.Overview

4.1.1.Market size and forecast

4.2.Acrylics

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market share analysis, by country

4.3.Polypropylene (PP)

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country

4.4.Polyvinylidene fluoride (PVDF)

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market share analysis, by country

4.5.Polysulfone (PSU) & Polyether Sulfone (PESU)

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market share analysis, by country

4.6.Polytetrafluoroethylene (PTFE)

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market share analysis, by country

4.7.Others

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market share analysis, by country

CHAPTER 5:MEDICAL MEMBRANE MARKET, BY TECHNOLOGY

5.1.Overview

5.1.1.Market size and forecast

5.3.Microfiltration

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country

5.4.Ultrafiltration

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country

5.5.Nanofiltration

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market share analysis, by country

5.6.Dialysis

5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market share analysis, by country

5.7.Gas Filtration

5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast, by region
5.7.3.Market share analysis, by country

5.8.Others

5.8.1.Key market trends, growth factors, and opportunities
5.8.2.Market size and forecast, by region
5.8.3.Market share analysis, by country

CHAPTER 6:MEDICAL MEMBRANE MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Pharmaceutical Filtration

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country

6.3.IV Infusion & Sterile Filtration

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country

6.4.Bio-Artificial Processes

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market share analysis, by country

6.5.Drug Delivery

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market share analysis, by country

6.6.Hemodialysis

6.6.1.Key market trends, growth factors, and opportunities
6.6.2.Market size and forecast, by region
6.6.3.Market share analysis, by country

6.8.Others

6.8.1.Key market trends, growth factors, and opportunities
6.8.2.Market size and forecast, by region
6.8.3.Market share analysis, by country

CHAPTER 7:MEDICAL MEMBRANE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by material
7.2.3.Market size and forecast, by technology
7.2.4.Market size and forecast, by application
7.2.6.Market size and forecast, by country
7.2.7.U.S.

7.2.7.1.Market size and forecast, by material
7.2.7.2.Market size and forecast, by technology
7.2.7.3.Market size and forecast, by application

7.2.8.Canada

7.2.8.1.Market size and forecast, by material
7.2.8.2.Market size and forecast, by technology
7.2.8.3.Market size and forecast, by application

7.2.9.Mexico

7.2.9.1.Market size and forecast, by material
7.2.9.2.Market size and forecast, by technology
7.2.9.3.Market size and forecast, by application

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by material
7.3.3.Market size and forecast, by technology
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country
7.3.6.Germany

7.3.6.1.Market size and forecast, by material
7.3.6.2.Market size and forecast, by technology
7.3.6.3.Market size and forecast, by application

7.3.7.UK

7.3.7.1.Market size and forecast, by material
7.3.7.2.Market size and forecast, by technology
7.3.7.3.Market size and forecast, by application

7.3.8.France

7.3.8.1.market size and forecast, by material
7.3.8.2.Market size and forecast, by technology
7.3.8.3.Market size and forecast, by application

7.3.9.Italy

7.3.9.1.Market size and forecast, by material
7.3.9.2.Market size and forecast, by technology
7.3.9.3.Market size and forecast, by application

7.3.10.Spain

7.3.10.1.Market size and forecast, by material
7.3.10.2.Market size and forecast, by technology
7.3.10.3.Market size and forecast, by application

7.3.11.Rest of Europe

7.3.11.1.Market size and forecast, by material
7.3.11.2.Market size and forecast, by technology
7.3.11.3.Market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by material
7.4.3.Market size and forecast, by technology
7.4.4.Market size and forecast, by application
7.4.6.Market size and forecast, by country
7.4.7.China

7.4.7.1.Market size and forecast, by material
7.4.7.2.Market size and forecast, by technology
7.4.7.3.Market size and forecast, by application

7.4.8.Japan

7.4.8.1.Market size and forecast, by material
7.4.8.2.Market size and forecast, by technology
7.4.8.3.Market size and forecast, by application

7.4.9.India

7.4.9.1.Market size and forecast, by material
7.4.9.2.Market size and forecast, by technology
7.4.9.3.Market size and forecast, by application

7.4.10.South Korea

7.4.10.1.Market size and forecast, by material
7.4.10.2.Market size and forecast, by technology
7.4.10.3.Market size and forecast, by application

7.4.11.Australia

7.4.11.1.Market size and forecast, by material
7.4.11.2.Market size and forecast, by technology
7.4.11.3.Market size and forecast, by application

7.4.12.Rest of Asia-Pacific

7.4.12.1.Market size and forecast, by material
7.4.12.2.Market size and forecast, by technology
7.4.12.3.Market size and forecast, by application

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by material
7.5.3.Market size and forecast, by technology
7.5.4.Market size and forecast, by application
7.5.6.Market size and forecast, by country
7.5.7.Brazil

7.5.7.1.Market size and forecast, by material
7.5.7.2.Market size and forecast, by technology
7.5.7.3.Market size and forecast, by application

7.5.8.Saudi Arabia

7.5.8.1.Market size and forecast, by material
7.5.8.2.Market size and forecast, by technology
7.5.8.3.Market size and forecast, by application

7.5.9.South Africa

7.5.9.1.Market size and forecast, by material
7.5.9.2.Market size and forecast, by technology
7.5.9.3.Market size and forecast, by application

7.5.10.Rest of LAMEA

7.5.10.1.Market size and forecast, by material
7.5.10.2.Market size and forecast, by technology
7.5.10.3.Market size and forecast, by application

CHAPTER 8:COMPETITIVE LANDSCAPE

8.1.INTRODUCTION

8.1.1.MARKET PLAYER POSITIONING, 2018

8.2.TOP WINNING STRATEGIES

8.2.1.Top winning strategies, by year
8.2.2.Top winning strategies, by development
8.2.3.Top winning strategies, by company

8.3.PRODUCT MAPPING OF TOP 10 PLAYER
8.4.COMPETITIVE HEATMAP
8.5.KEY DEVELOPMENTS

8.5.1.New product launches
8.5.2.Expansions
8.5.3.Mergers and acquisition

CHAPTER 9:COMPANY PROFILES:

9.1.Amniox Medical

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Product portfolio

9.2.Asahi Kasei

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.Danaher Corporation

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance

9.4.Hangzhou Cobetter Filtration Equipment

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Product portfolio

9.5.Koch Membrane Systems

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments

9.6.Mann+Hummel

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments

9.7.Merck Group

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.Sartorius AG

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance

9.9.W. L. Gore & Associates

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio

9.10.3M Company

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance

LIST OF TABLES

TABLE 01.MEDICAL MEMBRANE MARKET REVENUE, BY MATERIAL, 2019–2027($MILLION)
TABLE 02.MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 03.MEDICAL MEMBRANE MARKET FOR ACRYLICS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.MEDICAL MEMBRANE MARKET FOR POLYPROPYLENE (PP) , BY REGION, 2019–2027 ($MILLION)
TABLE 05.MEDICAL MEMBRANE MARKET FOR POLYVINYLIDENE FLUORIDE (PVDF), BY REGION, 2019–2027 ($MILLION)
TABLE 06.MEDICAL MEMBRANE MARKET FOR POLYSULFONE (PSU) & POLYETHER SULFONE (PESU), BY REGION, 2019–2027 ($MILLION)
TABLE 07.MEDICAL MEMBRANE MARKET FOR POLYTETRAFLUOROETHYLENE (PTFE), BY REGION, 2019–2027 ($MILLION)
TABLE 08.MEDICAL MEMBRANE MARKET FOR OTHERS , BY REGION, 2019–2027 ($MILLION)
TABLE 09.MEDICAL MEMBRANE MARKET REVENUE, BY TECHNOLOGY 2019–2027, ($MILLION)
TABLE 10.MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 11.MEDICAL MEMBRANE MARKET FOR MICROFILTRATION, BY REGION, 2019–2027 ($MILLION)
TABLE 12.MEDICAL MEMBRANE MARKET FOR ULTRAFILTRATION, BY REGION, 2019–2027 ($MILLION)
TABLE 13.MEDICAL MEMBRANE MARKET FOR NANOFILTRATION, BY REGION, 2019–2027 ($MILLION)
TABLE 14.MEDICAL MEMBRANE MARKET FOR DIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 15.MEDICAL MEMBRANE MARKET FOR GAS FILTRATION, BY REGION, 2019–2027 ($MILLION)
TABLE 16.MEDICAL MEMBRANE MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 17.MEDICAL MEMBRANE MARKET REVENUE, BY APPLICATION 2019–2027, ($MILLION)
TABLE 18.MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 19.MEDICAL MEMBRANE MARKET FOR PHARMACEUTICAL FILTRATION, BY REGION, 2019–2027 ($MILLION)
TABLE 20.MEDICAL MEMBRANE MARKET FOR IV INFUSION & STERILE FILTRATION, BY REGION, 2019–2027 ($MILLION)
TABLE 21.MEDICAL MEMBRANE MARKET FOR BIO-ARTIFICIAL PROCESSES, BY REGION, 2019–2027 ($MILLION)
TABLE 22.MEDICAL MEMBRANE MARKET FOR DRUG DELIVERY, BY REGION, 2019–2027 ($MILLION)
TABLE 23.MEDICAL MEMBRANE MARKET FOR HEMODIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 24.MEDICAL MEMBRANE MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 25.MEDICAL MEMBRANE MARKET, BY REGION 2019–2027 ($MILLION)
TABLE 26.NORTH AMERICA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.NORTH AMERICA MEDICAL MEMBRANE MARKET, BY COUNTRY 2019–2027 ($MILLION)
TABLE 30.U.S. MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 31.U.S. MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 32.U.S. MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 33.CANADA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 34.CANADA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 35.CANADA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 36.MEXICO MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 37.MEXICO MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 38.MEXICO MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.EUROPE MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 40.EUROPE MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 41.EUROPE MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 42.EUROPE MEDICAL MEMBRANE MARKET, BY COUNTRY 2019–2027 ($MILLION)
TABLE 43.GERMANY MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 44.GERMANY MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 45.GERMANY MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 46.UK MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 47.UK MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 48.UK MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 49.FRANCE MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 50.FRANCE MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 51.FRANCE MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 52.ITALY MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 53.ITALY MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 54.ITALYMEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 55.SPAIN MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 56.SPAIN MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 57.SPAIN MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 58.REST OF EUROPE MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 59.REST OF EUROPE MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 60.REST OF EUROPE MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.ASIA-PACIFIC MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 62.ASIA-PACIFIC MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 63.ASIA-PACIFIC MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 64.ASIA-PACIFIC MEDICAL MEMBRANE MARKET, BY COUNTRY 2019–2027 ($MILLION)
TABLE 65.CHINA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 66.CHINA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 67.CHINA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 68.JAPAN MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 69.JAPAN MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 70.JAPAN MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 71.INDIA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 72.INDIA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 73.INDIA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 74.SOUTH KOREA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 75.SOUTH KOREA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 76.SOUTH KOREA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 77.AUSTRALIA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 78.AUSTRALIA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 79.AUSTRALIA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 80.REST OF ASIA-PACIFIC MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 81.REST OF ASIA-PACIFIC MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 82.REST OF ASIA-PACIFIC MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 83.LAMEA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 84.LAMEA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 85.LAMEA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 86.LAMEA MEDICAL MEMBRANE MARKET, BY COUNTRY 2019–2027 ($MILLION)
TABLE 87.BRAZIL MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 88.BRAZIL MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 89.BRAZIL MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 90.SAUDI ARABIA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 91.SAUDI ARABIA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 92.SAUDI ARABIA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 93.SOUTH AFRICA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 94.SOUTH AFRICA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 95.SOUTH AFRICA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 96.REST OF LAMEA MEDICAL MEMBRANE MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 97.REST OF LAMEA MEDICAL MEMBRANE MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 98.REST OF LAMEA MEDICAL MEMBRANE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 99.KEY NEW PRODUCT LAUNCHES (2017-2019)
TABLE 100.KEY EXPANSIONS (2017-2019)
TABLE 101.KEY MERGERS AND ACQUISITION (2017-2019)
TABLE 102.AMNIOX: COMPANY SNAPSHOT
TABLE 103.AMNIOX: PRODUCT PORTFOLIO
TABLE 104.ASAHI KASEI: COMPANY SNAPSHOT
TABLE 105.ASAHI KASEI: OPERATING SEGMENTS
TABLE 106.ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 107.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 108.ASAHI KASEI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109.DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 110.DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 111.DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 112.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 113.COBETTER FILTRATION: COMPANY SNAPSHOT
TABLE 114.COBETTER FILTRATION: PRODUCT PORTFOLIO
TABLE 115.KOCH MEMBRANE: COMPANY SNAPSHOT
TABLE 116.KOCH MEMBRANE: PRODUCT PORTFOLIO
TABLE 117.KOCH MEMBRANE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118.MANN+HUMMEL: COMPANY SNAPSHOT
TABLE 119.MANN+HUMMEL: OPERATING SEGMENTS
TABLE 120.MANN+HUMMEL: PRODUCT PORTFOLIO
TABLE 121.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 122.MANN+HUMMEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123.MERCK: COMPANY SNAPSHOT
TABLE 124.MERCK: OPERATING SEGMENTS
TABLE 125.MERCK: PRODUCT PORTFOLIO
TABLE 126.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 127.MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128.SARTORIUS: COMPANY SNAPSHOT
TABLE 129.SARTORIUS: OPERATING SEGMENTS
TABLE 130.SARTORIUS: PRODUCT PORTFOLIO
TABLE 131.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 132.W. L. GORE & ASSOCIATES: COMPANY SNAPSHOT
TABLE 133.W. L. GORE & ASSOCIATES: PRODUCT PORTFOLIO
TABLE 134.3M COMPANY SNAPSHOT
TABLE 135.3M: OPERATING SEGMENTS
TABLE 136.3M: PRODUCT PORTFOLIO
TABLE 137.OVERALL FINANCIAL STATUS ($MILLION)

LIST OF FIGURES

FIGURE 01.GLOBAL MEDICAL MEMBRANE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS, BY MATERIAL (2019)
FIGURE 03.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04.LOW BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.HIGH INTENSITY OF COMPETITIVE RIVALRY
FIGURE 08.MEDICAL MEMBRANE MARKET DYNAMICS
FIGURE 09.PATENT ANALYSIS, BY COUNTRY
FIGURE 10.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR ACRYLICS, BY COUNTRY, 2019& 2027($MILLION)
FIGURE 11.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR POLYPROPYLENE (PP) , BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR POLYVINYLIDENE FLUORIDE (PVDF), BY COUNTRY, 2019& 2027($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR POLYSULFONE (PSU) & POLYETHER SULFONE (PESU), BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR POLYTETRAFLUOROETHYLENE (PTFE), BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR OTHERS , BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR MICROFILTRATION, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR ULTRAFILTRATION, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR NANOFILTRATION, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR DIALYSIS, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR GAS FILTRATION, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR OTHERS, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR PHARMACEUTICAL FILTRATION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR IV INFUSION & STERILE FILTRATION, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR BIO-ARTIFICIAL PROCESSES, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR DRUG DELIVERY, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR HEMODIALYSIS, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 27.COMPARATIVE ANALYSIS OF MEDICAL MEMBRANE MARKET FOR OTHERS, BY COUNTRY, 2019& 2027 ($MILLION)
FIGURE 28.U.S. REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 29.CANADA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 30.MEXICO REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 31.GERMANY REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 32.UK REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 33.FRANCE REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 34.ITALY REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 35.SPAIN REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 36.REST OF EUROPE REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 37.CHINA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 38.JAPAN REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 39.INDIA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 40.SOUTH KOREA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 41.AUSTRALIA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 42.REST OF ASIA-PACIFIC REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 43.BRAZIL REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 44.SAUDI ARABIA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 45.SOUTH AFRICA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 46.REST OF LAMEA REVENUE FOR MEDICAL MEMBRANE 2019–2027, ($MILLION)
FIGURE 47.MARKET PLAYER POSITIONING, 2018
FIGURE 48.TOP WINNING STRATEGIES, BY YEAR, 2017–2019
FIGURE 49.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2019 (%)
FIGURE 50.TOP WINNING STRATEGIES, BY COMPANY, 2017–2019
FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52.COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 53.ASAHI KASEI: REVENUE, 2017–2019 ($MILLION)
FIGURE 54.ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 55.ASAHI KASEI: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 56.DANAHER CORPORATION: REVENUE, 2017–2019 ($MILLION)
FIGURE 57.DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 58.DANAHER CORPORATION: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.MANN+HUMMEL: REVENUE, 2017–2019 ($MILLION)
FIGURE 60.MANN+HUMMEL: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 61.MERCK: REVENUE, 2017–2019 ($MILLION)
FIGURE 62.MERCK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 63.MERCK: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 64.SARTORIUS: REVENUE, 2017–2019 ($MILLION)
FIGURE 65.SARTORIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 66.SARTORIUS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 67.3M: NET SALES, 2017–2019 ($MILLION)
FIGURE 68.3M: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 69.3M: REVENUE SHARE BY REGION, 2019 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の医療用メンブレン市場2020年-2027年:材料別(アクリル、ポリプロピレン(PP)、ポリフッ化ビニリデン(PVDF)、ポリスルホン(PSU)&ポリエーテルスルホン(PESU)、ポリテトラフルオロエチレン(PTFE)、その他)、技術別、用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆